Showing results (21-30 of 527) with videos related to
Sort By:
Pageof 53
Current Rheumatology Reports|May 28, 2005
Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?Ted R Mikuls, Kenneth G SaagCurrent Osteoporosis Reports|February 27, 2007
Prevention and treatment of glucocorticoid-induced osteoporosisJeffrey R Curtis, Kenneth G SaagExpert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Improving the quality of clinical care for patients with osteoporosisKatri P Palonen, Kenneth G SaagCurrent Opinion in Endocrinology, Diabetes, and Obesity|January 29, 2014
Glucocorticoid-related bone changes from endogenous or exogenous glucocorticoidsAmy H Warriner, Kenneth G SaagCurrent Rheumatology Reports|March 29, 2012
From fracture risk prediction to evaluating fracture patterns: recent advances in the epidemiology of osteoporosisNicole C Wright, Kenneth G SaagCore Evidence|August 10, 2010
Febuxostat: the evidence for its use in the treatment of hyperuricemia and goutAngelo L Gaffo, Kenneth G SaagExpert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Evaluating and improving the quality of care in rheumatic diseaseJeffrey R Curtis, Kenneth G SaagCurrent Opinion in Rheumatology|February 8, 2006
New insights into gout epidemiologyTed R Mikuls, Kenneth G SaagJournal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 26, 2024
Methotrexate: Use in the Post Dobbs v. Jackson EraEdward M Huddleston, Kenneth G SaagCurrent Osteoporosis Reports|October 8, 2013
Prevention and treatment of bone changes associated with exposure to glucocorticoidsAmy H Warriner, Kenneth G SaagPageof 53